Fortress Biotech, Inc. (FBIO) 13D/13G Filings for Avenue Therapeutics, Inc. (ATXI)

Fortress Biotech, Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-02
5:00 pm
Purchase		 2025-03-31 13D Avenue Therapeutics, Inc.
ATXI		 Fortress Biotech Inc.
FBIO		 328,746
10.300%		 33,724increase
(+11.43%)		 Filing
2025-01-03
5:50 pm
Purchase		 2024-12-31 13D Avenue Therapeutics, Inc.
ATXI		 Fortress Biotech Inc.
FBIO		 295,022
13.800%		 114,597increase
(+63.52%)		 Filing
2024-11-15
4:05 pm
Purchase		 2024-11-13 13D Avenue Therapeutics, Inc.
ATXI		 Fortress Biotech Inc.
FBIO		 180,425
8.900%		 180,425increase
(New Position)		 Filing